Lupin: Strong quarterly results, great management commentary
Strong Fundamentally and focus on innovations
3rd largest generic company in USA
Breaking 10 year high.
Initiating buy position with 3600 target in short term
Strong Fundamentally and focus on innovations
3rd largest generic company in USA
Breaking 10 year high.
Initiating buy position with 3600 target in short term
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.